Teladoc Health, Inc. $TDOC Shares Sold by Entropy Technologies LP

Key Points

• Entropy Technologies LP has significantly reduced its stake in Teladoc Health, Inc., selling 68,499 shares to decrease its holdings by 80% in the first quarter, leaving them with 17,161 shares worth approximately $137,000.
• Despite Entropy's sell-off, other institutional investors like Cambridge Investment Research Advisors and Golden State Wealth Management have increased their positions in Teladoc, showcasing mixed investor sentiment surrounding the stock.
• Teladoc Health's recent earnings report showed better-than-expected results with a revenue of $631.90 million, surpassing analysts' estimates, although it indicates a year-over-year revenue decline of 1.6%.

Entropy Technologies LP lessened its position in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 80.0% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 17,161 shares of the health services provider's stock after selling 68,499 shares during the quarter. Entropy Technologies LP's holdings in Teladoc Health were worth $137,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in TDOC. Point72 Asset Management L.P. lifted its position in shares of Teladoc Health by 33.6% in the fourth quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider's stock valued at $101,625,000 after acquiring an additional 2,813,568 shares in the last quarter. Maple Rock Capital Partners Inc. lifted its position in Teladoc Health by 189.5% during the fourth quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider's stock worth $32,369,000 after buying an additional 2,331,000 shares in the last quarter. Two Sigma Investments LP purchased a new position in Teladoc Health during the fourth quarter worth approximately $18,348,000. Two Sigma Advisers LP lifted its position in Teladoc Health by 213.0% during the fourth quarter. Two Sigma Advisers LP now owns 2,258,711 shares of the health services provider's stock worth $20,532,000 after buying an additional 1,537,094 shares in the last quarter. Finally, Vanguard Group Inc. lifted its position in Teladoc Health by 7.0% during the first quarter. Vanguard Group Inc. now owns 19,752,338 shares of the health services provider's stock worth $157,229,000 after buying an additional 1,289,183 shares in the last quarter. Hedge funds and other institutional investors own 76.82% of the company's stock.

Insider Activity

In related news, insider Carlos Nueno sold 3,958 shares of the business's stock in a transaction on Monday, June 2nd. The stock was sold at an average price of $6.86, for a total transaction of $27,151.88. Following the completion of the transaction, the insider directly owned 17,645 shares of the company's stock, valued at $121,044.70. The trade was a 18.32% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Fernando M. Rodrigues sold 4,174 shares of the business's stock in a transaction on Tuesday, June 3rd. The stock was sold at an average price of $6.91, for a total value of $28,842.34. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 18,656 shares of company stock valued at $128,189. 0.58% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. Evercore ISI lifted their price objective on Teladoc Health from $7.00 to $8.00 and gave the stock an "in-line" rating in a research report on Wednesday, July 9th. Stifel Nicolaus reduced their price objective on Teladoc Health from $9.00 to $8.00 and set a "hold" rating on the stock in a research report on Thursday, May 1st. The Goldman Sachs Group reduced their price objective on Teladoc Health from $13.00 to $10.00 and set a "buy" rating on the stock in a research report on Thursday, May 1st. Mizuho initiated coverage on Teladoc Health in a research report on Friday, July 25th. They set a "neutral" rating and a $10.00 price objective on the stock. Finally, Bank of America cut their target price on Teladoc Health from $8.00 to $7.00 and set a "neutral" rating for the company in a research note on Wednesday, May 28th. Seven investment analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company. According to MarketBeat, Teladoc Health presently has a consensus rating of "Hold" and an average target price of $9.76.

Teladoc Health Trading Down 2.1%

Shares of NYSE TDOC traded down $0.1550 during trading on Tuesday, reaching $7.3350. The stock had a trading volume of 4,786,488 shares, compared to its average volume of 6,996,736. Teladoc Health, Inc. has a fifty-two week low of $6.35 and a fifty-two week high of $15.21. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.58 and a current ratio of 2.67. The business's 50-day moving average price is $7.72 and its 200-day moving average price is $8.28. The company has a market cap of $1.30 billion, a P/E ratio of -6.16 and a beta of 1.76.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share for the quarter, beating analysts' consensus estimates of ($0.27) by $0.08. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.The business had revenue of $631.90 million during the quarter, compared to analysts' expectations of $621.91 million. During the same period in the previous year, the firm posted ($0.38) earnings per share. The company's revenue was down 1.6% on a year-over-year basis. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. On average, equities research analysts predict that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.